HETLIOZ (TASIMELTEON) CAPSULES

View On IPO.GOV.AU

Protected: Registered/protected

Last updated on 11 Jul 2024

Owner Info

Vanda Pharmaceuticals Inc.

2200 Pennsylvania Ave. NW, Suite 300E

Washington, DC 20037, UNITED STATES OF AMERICA

Serial Number

1662290 filed on 5 Aug 2014

Correspondent

Jayme M. Torelli Hoffman Warnick LLC

540 Broadway, 4th Floor,

Albany NY 12207,

UNITED STATES OF AMERICA

HETLIOZ (TASIMELTEON) CAPSULES

Classification Information

1662290

5 Aug 2014

5 Aug 2034

FIGURATIVE

5 Feb 2014

Status Date	Action Taken
11^th Jul 2024	Renewal Requested
11^th Feb 2016	Goods and Services Classes
11^th Feb 2016	Goods and Services description amendment
5^th Nov 2015	Amendment to Application/Registration
11^th Jun 2015	IP Right Registration Published
3^rd Jun 2015	Register Trade Mark
3^rd Jun 2015	Application Status
17^th Apr 2015	Adhoc reprint of a Standard Notice correspondence sent
26^th Mar 2015	IP Right Acceptance Published
24^th Mar 2015	Clear Examination report approved